The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers
- Conditions
- Diabetic Foot UlcerSurgical Wound
- Registration Number
- NCT03905863
- Lead Sponsor
- Inotec AMD Limited
- Brief Summary
A Multicentre Randomized Controlled Trial to Investigate the Effect of Natrox Topical Oxygen Wound Therapy on the Healing rates of Diabetic Foot Ulcers.
- Detailed Description
Patients with diabetic foot ulcers will be enrolled into the trial at multiple wound care centers and hospital research centers across the United States of America. After qualifying per protocol, patients will be randomized to receive standard wound care or standard wound care plus Topical Oxygen Wound Therapy for their wounds. Patients will be monitored for 12 weeks. The primary comparator between the groups will be complete wound healing at 12 weeks, but other parameters will be assessed, such as pain, wound size reduction and infection status.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 145
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of Participants That Achieve Complete Wound Closure During the Twelve Week Study and the Percentage Change in Participant Ulcer Size at 12 Weeks From Baseline. Twelve (12) weeks from Time 0 Photographic wound evaluation and measurements were conducted utilizing an AI-driven computerized planimetry imaging system (Tissue Analytics, Inc., Baltimore, MD USA).15 This system obtained both 2D and 3D assessments of the wound at each visit through a standardized mobile device; in addition, the lead investigator reviewed all digital images.
Percentage Reduction in Ulcer Area (cm^2). Twelve (12) weeks from Time 0 Wound size change over time using a wound imaging measurement system. Percentage change in ulcer area was calculated on the basis of area change from the start of the study to the final recorded value. Any healed ulcer was recorded as having achieved 100% reduction in area; positive values indicate a reduction in size over the 12-week period while negative values indicate that the ulcer increased in size.
- Secondary Outcome Measures
Name Time Method Level of Pain of the Wound Up to twelve (12) weeks from Time 0 Does pain associated with the wound change over time using a Visual Analogue Scale Pain intensity of the reference DFU is to be assessed before any dressing changes or other ulcer manipulations at all screening and treatment visits.
Subject will be asked to indicate a numerical value that best represents the pain intensity at ulcer site on a scale of 0 to 10 anchored by word descriptors at each end, as "no pain" on the left side and "worst possible pain" on the right side of the number line. The number 0 represent "no pain", the number 5 represents "moderate pain" and the number 10 represents the "worst possible pain". The subject indicates the level of pain intensity by selecting a number on the line that represents their perception of their current state.Number of Adverse Events Up to twelve (12) weeks from time 0 Number of adverse events, such as infections, that are found associated with the study wound
Trial Locations
- Locations (20)
New Hope Podiatry Clinic
🇺🇸Los Angeles, California, United States
San Marcus Research Clinic
🇺🇸Miami Lakes, Florida, United States
Global Health Research Center Inc
🇺🇸Miami Lakes, Florida, United States
MedCare Research
🇺🇸Miami, Florida, United States
Barry University Clinical Research
🇺🇸North Miami Beach, Florida, United States
Royal Research Corp
🇺🇸Pembroke Pines, Florida, United States
Doctors Research Network
🇺🇸South Miami, Florida, United States
Pharma Research Associates
🇺🇸Westchester, Florida, United States
Wahab Consulting and Research
🇺🇸Las Vegas, Nevada, United States
Cleveland Foot and Ankle Clinic
🇺🇸Cleveland, Ohio, United States
Scroll for more (10 remaining)New Hope Podiatry Clinic🇺🇸Los Angeles, California, United States